HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria A Sullivan Selected Research

Naltrexone (ReVia)

1/2022Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended-release naltrexone in a residential setting.
1/2022Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials.
11/2021Patterns of withdrawal in patients with opioid use disorder (OUD) transitioning from untreated OUD or buprenorphine treatment to extended-release naltrexone.
1/2021Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018.
12/2020Cognitive performance of patients with opioid use disorder transitioned to extended-release injectable naltrexone from buprenorphine: Post hoc analysis of exploratory results of a phase 3 randomized controlled trial.
1/2020Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism.
1/2020Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens.
7/2019Psychoeducational Strategies During Outpatient Transition to Extended-Release Naltrexone for Patients With Opioid Use Disorder.
1/2019A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder.
1/2018Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria A Sullivan Research Topics

Disease

34Opioid-Related Disorders (Opiate Addiction)
01/2022 - 12/2002
11Pain (Aches)
08/2017 - 03/2006
9Substance Withdrawal Syndrome (Withdrawal Symptoms)
11/2021 - 05/2008
7Substance-Related Disorders (Drug Abuse)
04/2015 - 09/2005
4Chronic Pain
08/2013 - 01/2011
3Marijuana Abuse (Cannabis Abuse)
02/2016 - 10/2002
2Opiate Overdose
01/2021 - 09/2005
2Depressive Disorder (Melancholia)
11/2014 - 06/2013
2Weight Gain
01/2011 - 11/2010
2Heroin Dependence (Heroin Abuse)
10/2010 - 12/2007
2Alcoholism (Alcohol Abuse)
11/2006 - 10/2002
2Tobacco Use Disorder (Nicotine Dependence)
10/2002 - 02/2002
1Mental Disorders (Mental Disorder)
01/2018
1Asthma (Bronchial Asthma)
08/2017
1Dizziness (Lightheadedness)
08/2017
1Acquired Immunodeficiency Syndrome (AIDS)
01/2017
1Miosis
05/2016
1Muscle Cramp (Cramp)
01/2016
1Marijuana Use
11/2014
1Psychomotor Agitation (Akathisia)
04/2014
1Restless Legs Syndrome (Restless Legs)
04/2014
1Seizures (Absence Seizure)
01/2014
1Mood Disorders (Mood Disorder)
01/2014
1Confusion (Bewilderment)
01/2014
1Cocaine-Related Disorders (Cocaine Addiction)
05/2011
1Funnel Chest (Pectus Excavatum)
03/2011
1Sickle Cell Anemia (Hemoglobin S Disease)
03/2011
1Postoperative Pain
03/2011
1Scoliosis
03/2011
1Weight Loss (Weight Reduction)
01/2011
1Syndrome (Syndromes)
01/2011
1Mania (Manias)
10/2005
1Psychotic Disorders (Schizoaffective Disorder)
10/2005
1Drug Overdose
09/2005

Drug/Important Bio-Agent (IBA)

27Opioid Analgesics (Opioids)IBA
01/2022 - 10/2002
27Naltrexone (ReVia)FDA LinkGeneric
01/2022 - 12/2002
9Buprenorphine (Subutex)FDA LinkGeneric
01/2022 - 11/2004
6Pharmaceutical PreparationsIBA
01/2018 - 10/2002
5Heroin (Diamorphine)IBA
02/2015 - 09/2005
4Narcotic Antagonists (Opioid Antagonists)IBA
11/2021 - 11/2006
4Naloxone Drug Combination BuprenorphineFDA Link
01/2018 - 04/2010
4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2014 - 08/2007
4Methadone (Dolophine)FDA LinkGeneric
05/2013 - 11/2004
3Oxycodone (Oxycontin)FDA LinkGeneric
08/2017 - 01/2011
3Analgesics (Analgesic Drugs)IBA
08/2017 - 01/2011
3Memantine (Namenda)FDA Link
05/2014 - 08/2007
3Antidepressive Agents (Antidepressants)IBA
01/2014 - 02/2002
3N-Methylaspartate (NMDA)IBA
12/2011 - 08/2007
3Opiate AlkaloidsIBA
12/2011 - 11/2010
2vivitrolFDA Link
01/2018 - 11/2013
2ibudilastIBA
08/2017 - 01/2016
2Dronabinol (THC)FDA LinkGeneric
02/2016 - 11/2014
2Morphine (MS Contin)FDA LinkGeneric
01/2016 - 05/2008
2Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
11/2014 - 06/2013
2Gabapentin (Neurontin)FDA LinkGeneric
04/2014 - 05/2013
2Dextromethorphan (Racemethorphan)FDA LinkGeneric
11/2011 - 05/2008
2Cocaine (Cocaine HCl)IBA
05/2011 - 10/2002
2Opioid Receptors (Opioid Receptor)IBA
01/2011 - 07/2009
2Estradiol (Delestrogen)FDA LinkGeneric
04/2010 - 03/2006
2Oral ContraceptivesIBA
04/2010 - 03/2006
13,3'- di- (N- cyclopropylmethyl- 4,5- epoxy- 14- hydroxymorphinan- 6- one- 3- yl)carbonateIBA
01/2020
1Delayed-Action PreparationsIBA
01/2020
1SuspensionsIBA
01/2019
1Phosphodiesterase InhibitorsIBA
08/2017
1lofexidineIBA
02/2016
1CannabinoidsIBA
09/2015
1BenzodiazepinesIBA
04/2014
1Quetiapine Fumarate (Seroquel)FDA Link
04/2014
1Olanzapine (Zyprexa)FDA Link
04/2014
1Antipsychotic Agents (Antipsychotics)IBA
04/2014
1Therapeutic UsesIBA
04/2014
1Naproxen (Naprosyn)FDA LinkGeneric
05/2013
1Tramadol (K315)FDA LinkGeneric
05/2013
1Hydromorphone (Dilaudid)FDA LinkGeneric
05/2013
1Quinidine (Chinidin)FDA LinkGeneric
11/2011
1Narcotics (Narcotic Analgesics)IBA
03/2011
1Hormones (Hormone)IBA
04/2010
1Peptides (Polypeptides)IBA
07/2009
1Dynorphins (Dynorphin)IBA
07/2009
1Dopamine (Intropin)FDA LinkGeneric
07/2009
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
07/2009
1DextrorphanIBA
05/2008
1ProgesteroneFDA LinkGeneric
03/2006
1Gonadal HormonesIBA
03/2006
1NicotineFDA Link
10/2002
1Anti-Anxiety Agents (Anxiolytics)IBA
02/2002

Therapy/Procedure

9Injections
01/2022 - 02/2006
7Therapeutics
01/2019 - 12/2002
2Analgesia
08/2017 - 06/2012
1Pain Management
01/2016
1Secondary Prevention
05/2014
1Drug Therapy (Chemotherapy)
04/2014
1Self Administration (Administration, Self)
08/2013
1Patient-Controlled Analgesia (Analgesia, Patient Controlled)
05/2013
1Glycemic Control
11/2010
1Involuntary Commitment
01/2007
1Aftercare (After-Treatment)
09/2005